About Solstice Pharmaceuticals
Solstice Pharmaceuticals is a company based in Enschede (Netherlands) founded in 2020. Solstice Pharmaceuticals offers products and services including Harmono-T® and Activation Station. Solstice Pharmaceuticals operates in a competitive market with competitors including On Target Laboratories, Guerbet, Osprey Medical, RenalGuard Solutions and Cision Vision, among others.
- Headquarter Enschede, Netherlands
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Solstice Pharmaceuticals B.V.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$56.54 K (USD), Grant
Feb 01, 2015
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Solstice Pharmaceuticals
Solstice Pharmaceuticals offers a comprehensive portfolio of products and services, including Harmono-T® and Activation Station.
Enhances ultrasound images for improved diagnostic accuracy in medical procedures.
Activates contrast agents at bedside for uniform enhancement during examinations.
Funding Insights of Solstice Pharmaceuticals
Investors in Solstice Pharmaceuticals
Solstice Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Solstice Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Solstice Pharmaceuticals
Investment portfolio details for Solstice Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Solstice Pharmaceuticals
Detailed financials for Solstice Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Solstice Pharmaceuticals Comparisons
Peer comparison for Solstice Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Solstice Pharmaceuticals
Solstice Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as On Target Laboratories, Guerbet, Osprey Medical, RenalGuard Solutions and Cision Vision, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular imaging agents for cancer surgery are developed.
|
|
| Locked | Locked | Locked |
Contrast agents and delivery systems are developed for medical imaging.
|
|
| Locked | Locked | Locked |
Technology to reduce contrast dye exposure
|
|
| Locked | Locked | Locked |
Technologies for the cardiac and vascular markets
|
|
| Locked | Locked | Locked |
High contrast real-time imaging devices are developed for medical visualization.
|
Detailed competitors of Solstice Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Solstice Pharmaceuticals
Complete news archive for Solstice Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Solstice Pharmaceuticals
Solstice Pharmaceuticals was founded in 2020.
Solstice Pharmaceuticals is headquartered in Enschede, Netherlands. It is registered at Enschede, Overijssel, Netherlands.
Solstice Pharmaceuticals was founded in 2020 in Enschede, Netherlands, within the pharmaceuticals sector. Ultrasound contrast agents are developed by the company for diagnosing various diseases. Proprietary technology is utilized to create Harmono-T, an intravenous agent featuring lipid-coated gas microbubbles. Ultrasound images are enhanced through this product, enabling clinicians to assess organ perfusion and peripheral vasculature function. Operations focus on advancing diagnostic imaging solutions.
Solstice Pharmaceuticals's top competitors include Guerbet, On Target Laboratories and Osprey Medical.
Solstice Pharmaceuticals offers Harmono-T® and Activation Station.
Solstice Pharmaceuticals has 1 investor. Key investors include European Union.